Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 364

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 364
---
 meeting
of its stockholders (the “Second Special Meeting”). At the Second Special Meeting, the Company’s stockholders approved
an amendment to the IMTA, as amended by the IMTA Amendment (the “Second IMTA Amendment”), and an amendment to the Company’s
Charter, as amended by the Charter Amendment (the “Second Charter Amendment”), to extend the business combination period
for up to six times for one month each time (the “Second Extension”).

On July 7, 2023, July 28, 2023, September 1, 2023,
October 4, 2023, November 2, 2023 and November 30, 2023, the Company deposited $37,052, $8,846, $22,949, $22,949, $22,949 and $22,949
into the Trust Account in connection with the Second Extension.

As a result of the deposits described above, such
payments and accrual of interest, the balance in the Trust Account as of December 31, 2023 is approximately $8.4 million.

If the Company is unable to complete a business
combination by January 8, 2024 (as extended) (the “business combination period”), the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to us to pay the Company’s franchise and income
taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to
the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Initial Stockholders have agreed to waive their
liquidation rights with respect to the Founder Shares and Private Placement Shares if the Company fails to complete a business combination
within the business